RESEARCHER PROFILE

Ozan Cem Güler

← Back to Başkent University

O

Başkent University

Prostate Cancer Diagnosis and TreatmentAdvanced Radiotherapy TechniquesEndometrial and Cervical Cancer TreatmentsBreast Cancer Treatment StudiesMedical Imaging Techniques and Applications

Ozan Cem Güler works in Prostate Cancer Diagnosis and Treatment, Advanced Radiotherapy Techniques, Endometrial and Cervical Cancer Treatments, Breast Cancer Treatment Studies, Medical Imaging Techniques and Applications. Recorded institutional associations include Rutgers, The State University of New Jersey, Başkent University.

248Publications
1,576Citations
22H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy

    2018 · 57 citations
  2. Prognostic Value of Pretreatment 18F-fluorodeoxyglucose Uptake in Patients With Cervical Cancer Treated With Definitive Chemoradiotherapy

    2013 · 56 citations
  3. Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer

    2016 · 50 citations
  4. Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy

    2016 · 48 citations
  5. The feasibility of prostate-specific membrane antigen positron emission tomography(PSMA PET/CT)-guided radiotherapy in oligometastatic prostate cancer patients

    2017 · 47 citations
  6. Prognostic value of 18F-fluorodeoxyglucose uptake in pelvic lymph nodes in patients with cervical cancer treated with definitive chemoradiotherapy

    2015 · 46 citations
  7. The effect of androgen deprivation therapy on 68Ga-PSMA tracer uptake in non-metastatic prostate cancer patients

    2019 · 45 citations
  8. Simultaneous integrated boost to intraprostatic lesions using different energy levels of intensity-modulated radiotherapy and volumetric-arc therapy

    2013 · 44 citations
  9. Treatment outcomes of metastasis-directed treatment using 68Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)

    2020 · 42 citations
  10. Treatment outcomes of patients with cervical cancer with complete metabolic responses after definitive chemoradiotherapy

    2014 · 38 citations
  11. Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients

    2021 · 37 citations
  12. Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer Patients

    2019 · 34 citations
  13. Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastases

    2019 · 33 citations
  14. A multi-institutional analysis of sequential versus ‘sandwich’ adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma

    2018 · 32 citations
  15. Definitive Chemoradiation Therapy Following Surgical Resection or Radiosurgery Plus Whole-Brain Radiation Therapy in Non-Small Cell Lung Cancer Patients With Synchronous Solitary Brain Metastasis: A Curative Approach

    2014 · 29 citations
  16. Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide

    2018 · 29 citations
  17. Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration‐resistant prostate cancer patients during abiraterone/enzalutamide treatment

    2021 · 29 citations
  18. Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images

    2016 · 27 citations
  19. Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients

    2020 · 25 citations
  20. Stereotactic radiotherapy in patients with oligometastatic or oligoprogressive gynecological malignancies: a multi-institutional analysis

    2020 · 24 citations
  21. Pretreatment metabolic tumour volume and total lesion glycolysis are not independent prognosticators for locally advanced cervical cancer patients treated with chemoradiotherapy

    2018 · 23 citations
  22. Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated With Stereotactic Body Radiotherapy Using 68Ga-PSMA PET/CT

    2021 · 22 citations
  23. Chemoradiotherapy-induced hemoglobin nadir values and survival in patients with stage III non-small cell lung cancer

    2018 · 21 citations
  24. The Utility of Pretreatment and Posttreatment Lymphopenia in Cervical Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy

    2018 · 21 citations
  25. Treatment outcomes of simultaneous integrated boost to intraprostatic lesions with external beam radiotherapy in localized prostate cancer patients

    2023 · 20 citations

← Return to the university profile